NEW YORK (GenomeWeb) – WaferGen Biosystems announced today that it has completed an offering of common stock and warrants that brought in gross proceeds of $20 million.
The offering comprises 2,000 units priced at $10,000 per unit. Each unit consists of 2,000 shares of common stock and 2,000 warrants to purchase shares of the firm's common stock. In total, 4 million shares of common stock and warrants to purchase 4 million shares were issued in the offering. The warrants have a term of five years and an exercise price of $5 per share.
The offering brought in net proceeds of approximately $18 million. WaferGen said that it intends to use $1.3 million of the funds to repay existing debt, and the rest will be used for general corporate and working capital purposes.
Ladenburg Thalmann & Co. was the sole book-running manager for the offering, while National Securities Corp. and Brean Capital were co-managers on the offering.
Last Friday, when the firm announced the offering, its shares dropped more than 50 percent to close at $4.95. In afternoon trading today, WaferGen shares were up a fraction of 1 percent at $4.60.